New guidelines to help clinicians manage GSM in women with breast cancer

(The North American Menopause Society (NAMS)) Although the genitourinary syndrome of menopause (GSM) is more prevalent in survivors of breast cancer than in other menopausal women, it is commonly undiagnosed and untreated. This led NAMS and ISSWSH to form a multidisciplinary Consensus Panel to develop recommendations for clinicians to manage GSM in women with or at high risk for breast cancer. The recommendations are published online in NAMS' official journal, Menopause.